<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02704117</url>
  </required_header>
  <id_info>
    <org_study_id>P50MH106435</org_study_id>
    <nct_id>NCT02704117</nct_id>
  </id_info>
  <brief_title>Neurocircuitry of Obsessive-Compulsive Disorder: Modulation by Transcranial Magnetic Stimulation</brief_title>
  <official_title>Neurocircuitry of OCD: Effects Of Modulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Butler Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Harvard University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Puerto Rico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Butler Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the effects of non-invasive neuromodulation,&#xD;
      transcranial magnetic stimulation on brain function in individuals with obsessive-compulsive&#xD;
      disorder (OCD). This study is focused on the mechanism(s) by which brain stimulation might&#xD;
      change the functioning of regions implicated in OCD, and thereby inform possible future&#xD;
      therapeutic uses.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in activation of pre-supplementary motor area/dorsal anterior cingulate cortex (pSMA/dACC) on functional magnetic resonance imaging (fMRI) during the Multi-Source Interference task (MSIT)</measure>
    <time_frame>Baseline and 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Yale-Brown Obsessive Compulsive Scale (Y-BOCS)</measure>
    <time_frame>Baseline and 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Obsessive-Compulsive Disorder</condition>
  <arm_group>
    <arm_group_label>Transcranial Magnetic Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transcranial Magnetic Stimulation applied over the pre-supplementary motor area (pSMA), for ten sessions, Monday through Friday, over the course of two weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Magentic Stimulation</intervention_name>
    <description>This is a form of mild brain stimulation delivered noninvasively. The device delivers pulses of magnetic energy through a coil placed on the scalp. The treatment takes 41 seconds, and takes place for ten sessions, Monday through Friday, over the course of two weeks</description>
    <arm_group_label>Transcranial Magnetic Stimulation</arm_group_label>
    <other_name>Continuous Theta Burst Stimulation (cTBS)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Current primary OCD diagnosis and current Y-BOCS total score of â‰¥16&#xD;
&#xD;
          -  18-70 years of age&#xD;
&#xD;
          -  Ability to speak, read, write, and understand English sufficiently well to complete&#xD;
             study procedures and provide informed consent&#xD;
&#xD;
          -  No use of psychiatric medications or stable psychiatric medication use for a minimum&#xD;
             of 6 week prior to study entry&#xD;
&#xD;
          -  Ongoing psychotherapy allowed if already established for three months or more before&#xD;
             study entry&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of primary psychotic disorder or bipolar disorder&#xD;
&#xD;
          -  Present acute suicidality&#xD;
&#xD;
          -  History of head injury, epilepsy, or other clinically significant neurological illness&#xD;
             except tic disorders&#xD;
&#xD;
          -  Active systemic medical (metabolic, endocrine, chronic inflammatory, vascular,&#xD;
             autoimmune) disease&#xD;
&#xD;
          -  Premorbid intelligence quotient (IQ) estimate &lt; 80&#xD;
&#xD;
          -  Visual disturbance (&lt;20/40 Snellen visual acuity, corrected)&#xD;
&#xD;
          -  Current, or alcohol or illicit substance abuse/dependence in the last 3 months&#xD;
&#xD;
          -  Contraindications to TMS or MRI: metallic foreign objects, e.g., aneurysm&#xD;
             clips/pacemakers, or questionable history of metal fragments, claustrophobia&#xD;
&#xD;
          -  Women who are pregnant or breastfeeding. All women participants of reproductive age&#xD;
             are required to have a negative pregnancy test prior to enrollment and use medically&#xD;
             acceptable birth control throughout the study (barrier and/or oral contraceptives)&#xD;
&#xD;
          -  Current psychotic symptoms&#xD;
&#xD;
          -  An increased risk of seizure, determined by history&#xD;
&#xD;
          -  Medications judged to notably affect cortical excitability e.g., anticonvulsants or&#xD;
             high-dose benzodiazepines (&gt; 4 mg/day of clonazepam or equivalent)&#xD;
&#xD;
          -  Predominant hoarding symptoms&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Benjamin Greenberg, MD, PhD</last_name>
    <phone>(401) 455-6602</phone>
    <email>benjamin_greenberg@brown.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anna Sherman</last_name>
    <phone>(401) 455-6366</phone>
    <email>AnSherman@butler.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Butler Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Greenberg, MD, PhD</last_name>
      <phone>401-455-6602</phone>
      <email>benjamin_greenberg@brown.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://butler.org/stim</url>
    <description>Related Info</description>
  </link>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 29, 2016</study_first_submitted>
  <study_first_submitted_qc>March 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2016</study_first_posted>
  <last_update_submitted>September 17, 2021</last_update_submitted>
  <last_update_submitted_qc>September 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

